KR102662461B1 - 비염증성 병변의 치료 - Google Patents

비염증성 병변의 치료 Download PDF

Info

Publication number
KR102662461B1
KR102662461B1 KR1020207003934A KR20207003934A KR102662461B1 KR 102662461 B1 KR102662461 B1 KR 102662461B1 KR 1020207003934 A KR1020207003934 A KR 1020207003934A KR 20207003934 A KR20207003934 A KR 20207003934A KR 102662461 B1 KR102662461 B1 KR 102662461B1
Authority
KR
South Korea
Prior art keywords
methyl
inflammatory lesions
lesions
effective amount
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020207003934A
Other languages
English (en)
Korean (ko)
Other versions
KR20200031126A (ko
Inventor
데이비드 버크
알렉산드레 카우코프
빌마 스니우킨
카스텐 슈미츠
Original Assignee
알미랄 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알미랄 엘엘씨 filed Critical 알미랄 엘엘씨
Publication of KR20200031126A publication Critical patent/KR20200031126A/ko
Application granted granted Critical
Publication of KR102662461B1 publication Critical patent/KR102662461B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020207003934A 2017-07-21 2018-07-20 비염증성 병변의 치료 Active KR102662461B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762535572P 2017-07-21 2017-07-21
US62/535,572 2017-07-21
PCT/IB2018/000938 WO2019016609A1 (en) 2017-07-21 2018-07-20 TREATMENT OF NON-INFLAMMATORY LESIONS

Publications (2)

Publication Number Publication Date
KR20200031126A KR20200031126A (ko) 2020-03-23
KR102662461B1 true KR102662461B1 (ko) 2024-04-30

Family

ID=63713912

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020207003934A Active KR102662461B1 (ko) 2017-07-21 2018-07-20 비염증성 병변의 치료

Country Status (13)

Country Link
US (1) US20200222432A1 (https=)
EP (1) EP3654988B1 (https=)
JP (1) JP2020527607A (https=)
KR (1) KR102662461B1 (https=)
CN (1) CN111343991A (https=)
AU (1) AU2018303807B2 (https=)
BR (1) BR112020000968A2 (https=)
CA (1) CA3070663A1 (https=)
ES (1) ES2962380T3 (https=)
IL (1) IL272124A (https=)
MA (1) MA49641A (https=)
MX (1) MX2020000816A (https=)
WO (1) WO2019016609A1 (https=)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012155146A1 (en) * 2011-05-12 2012-11-15 Paratek Pharmaceuticals, Inc. Crystalline salts of (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the same

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990331A (en) 1956-11-23 1961-06-27 Pfizer & Co C Stable solutions of salts of tetracyclines for parenteral administration
US2980584A (en) 1957-10-29 1961-04-18 Pfizer & Co C Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation
US3062717A (en) 1958-12-11 1962-11-06 Pfizer & Co C Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation
US3165531A (en) 1962-03-08 1965-01-12 Pfizer & Co C 13-substituted-6-deoxytetracyclines and process utilizing the same
US3454697A (en) 1965-06-08 1969-07-08 American Cyanamid Co Tetracycline antibiotic compositions for oral use
NL6607516A (https=) 1966-05-31 1967-12-01
DE1767891C3 (de) 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
US3957980A (en) 1972-10-26 1976-05-18 Pfizer Inc. Doxycycline parenteral compositions
DE2442829A1 (de) 1974-09-06 1976-03-18 Merck Patent Gmbh Tetracyclische verbindungen und verfahren zu ihrer herstellung
US4018889A (en) 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
US4126680A (en) 1977-04-27 1978-11-21 Pfizer Inc. Tetracycline antibiotic compositions
AU2002303250B2 (en) * 2001-04-05 2006-05-25 Collagenex Pharmaceuticals, Inc. Methods of treating acne
US7704959B2 (en) * 2006-10-03 2010-04-27 Dow Pharmaceutical Sciences Azithromycin for the treatment of nodular acne
PL2109602T3 (pl) 2006-12-21 2014-09-30 Paratek Pharm Innc Pochodne tetracyliny do leczenia zakażeń bakteryjnych, wirusowych i pasożytniczych
PT2120963T (pt) 2006-12-21 2018-12-17 Paratek Pharm Innc Compostos tetraciclina substituídos para tratamento de distúrbios inflamatórios da pele
EP2280733A1 (en) * 2008-05-21 2011-02-09 Galderma Research & Development Maintenance therapy regimen for treating acne
CA2723029C (en) * 2008-06-05 2016-07-19 Dow Pharmaceutical Sciences, Inc. Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
CA2769640A1 (en) * 2009-07-30 2011-02-03 Allergan, Inc. Combination of dapsone with adapalene
US20140121188A1 (en) * 2009-10-02 2014-05-01 Foamix Ltd. Compositions for the improved treatment of acne and related disorders
IL225239A0 (en) * 2012-03-15 2013-06-27 Meir Eini Compounds for the treatment of acne and related diseases
GB201615693D0 (en) * 2016-09-15 2016-11-02 Combinatorx Infection Ltd Combinations

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012155146A1 (en) * 2011-05-12 2012-11-15 Paratek Pharmaceuticals, Inc. Crystalline salts of (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the same

Also Published As

Publication number Publication date
EP3654988B1 (en) 2023-09-06
US20200222432A1 (en) 2020-07-16
JP2020527607A (ja) 2020-09-10
KR20200031126A (ko) 2020-03-23
CN111343991A (zh) 2020-06-26
EP3654988A1 (en) 2020-05-27
AU2018303807B2 (en) 2023-08-24
CA3070663A1 (en) 2019-01-24
MX2020000816A (es) 2020-08-17
MA49641A (fr) 2021-06-02
AU2018303807A1 (en) 2020-02-13
IL272124A (en) 2020-03-31
WO2019016609A1 (en) 2019-01-24
ES2962380T3 (es) 2024-03-18
BR112020000968A2 (pt) 2020-07-14

Similar Documents

Publication Publication Date Title
CN105143174A (zh) 治疗帕金森疾病的新型高穿透力药物和医药组合物
CN102573823B (zh) 包含反式去甲舍曲林和血清素受体1a激动剂/拮抗剂的组合物及其用途
JP2021098695A (ja) （４ｓ，４ａｓ，５ａｒ，１２ａｓ）−４−ジメチルアミノ−３，１０，１２，１２ａ−テトラヒドロキシ−７−［（メトキシ（メチル）アミノ）−メチル］−１，１１−ジオキソ−１，４，４ａ，５，５ａ，６，１１，１２ａ−オクタヒドロ−ナフタセン−２−カルボン酸アミドの結晶塩及びそれを使用する方法
US11766430B2 (en) Methods of using a phenoxypropylamine compound to treat pain
CN109069450A (zh) 神经障碍的新的组合疗法
KR102662461B1 (ko) 비염증성 병변의 치료
CN112770765B (zh) 用于预防和/或治疗泌尿生殖器粘膜的组合物
CN104244942A (zh) 两性表面活性剂在预防和治疗阴道感染中的致病性阴道生物被膜中的应用
CN109310669A (zh) 氨基甲酸酯化合物用于预防或治疗三叉神经痛的用途
WO2024123825A1 (en) Nootkatone for the treatment of psoriasis or atopic dermatitis
HK40019815A (en) Sarecycline for the treatment of non-inflammatory acne lesions
HK40019815B (en) Sarecycline for the treatment of non-inflammatory acne lesions
CN1852729A (zh) 疮疱丙酸杆菌的抗菌剂
JP2023518430A (ja) 感染症の治療におけるブシラミンの使用
CN118574810A (zh) 用尼罗加司他治疗卵巢癌
US20230218653A1 (en) Pten inhibitors for treatment and prevention of bone marrow loss
JP2024518455A5 (https=)
JP2020527607A5 (https=)
TW202132291A (zh) 使用苯氧丙胺化合物治療疼痛的方法
JP2006117569A (ja) ステロイド依存性あるいはステロイド抵抗性潰瘍性大腸炎治療薬
WO2011101868A2 (en) Stable pharmaceutical preparations containing clindamycin and benzoyl peroxide and method thereof
CA3066904A1 (en) Bromhexine for the treatment of pain

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20200210

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20210624

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20230901

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20240326

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20240426

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20240426

End annual number: 3

Start annual number: 1

PG1601 Publication of registration